Delivery Order SPE2DB24D1205-SPE2DB25FCXPT
- Not listed
- The Defense Logistics Agency awarded a $2,749.98 delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Forteo (teriparatide) 560 mcg/2.24 mL pen injections. This firm fixed-price, non-set-aside contract is classified as a delivery order with an ultimate completion date of September 11, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. Forteo is a pharmaceutical product used to treat osteoporosis and bone-related...
- The Defense Logistics Agency awarded a delivery order valued at $3,666.64 to AmerisourceBergen Drug Corp for Forteo 560 mcg/2.24 mL pen injections on September 19, 2025, with an ultimate completion date of September 22, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Forteo is a bone-building medication used to treat osteoporosis in patients at high risk of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Forteo (teriparatide) 560 mcg/2.24 mL pen injections in a 2.24 mL formulation. This $4,289.89 firm fixed-price delivery order, issued on May 6, 2025, with an ultimate completion date of May 7, 2025, carries no set-aside designation and represents a competitively awarded contract. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a $13,965.22 delivery order to AmerisourceBergen Drug Corp for Forteo (560 mcg/2.24 mL pen injections) on June 18, 2025, with an ultimate completion date of June 20, 2025. This firm fixed-price contract, which was competitively awarded with no set-aside designation, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical. The contract will be performed at the company's corporate office...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 16, 2025, for the supply of Forteo (560 mcg/2.24 mL pen injections) with a firm fixed price ceiling value of $5,483.02. This non-competitive delivery order is expected to be completed by December 17, 2025, and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The contract represents a continuation of AmerisourceBergen's role as a critical pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $17,616.07 to AmerisourceBergen Drug Corp for Forteo (560 mcg/2.24 mL) pen injections on December 15, 2025, with completion scheduled for December 16, 2025. This competitively awarded, firm fixed-price delivery order represents a single pharmaceutical procurement supporting federal medical supply requirements. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 11, 2025, for the supply of Forteo 560 mcg/2.24 mL pen injections valued at $5,943.53. This is a firm fixed-price delivery order with no set-aside designation, demonstrating competitive award practices. The contract is set to conclude on December 12, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Forteo is a prescription medication used for...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on June 20, 2025, for the supply of Forteo 560 mcg/2.24 mL pen injections with a ceiling value of $2,932.25. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of June 23, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Forteo is a pharmaceutical treatment used primarily for osteoporosis management, reflecting...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $19,998.93 by the Defense Logistics Agency on November 12, 2025, for the supply of Forteo (teriparatide) 560 micrograms/2.24 milliliters pen injections. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of November 13, 2025, and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. Forteo is a prescription...
- The Defense Logistics Agency awarded a delivery order valued at $7,190.02 to AmerisourceBergen Drug Corp for the supply of Forteo 560 mcg/2.24 ml pen injections on July 24, 2025, with completion targeted for July 25, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Forteo is a pharmaceutical treatment commonly prescribed for osteoporosis management,...
- SPE2DB24D1205Indefinite Delivery Contract
- SPE2DB24D1205-SPE2DB25FCXPTDelivery Order
On June 10, 2025, the Defense Logistics Agency awarded a delivery order valued at $12,258.03 to AmerisourceBergen Drug Corp for Forteo (teriparatide) 560 mcg/2.24 mL pen injections. This firm fixed-price, non-set-aside delivery order is scheduled for completion by June 11, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Forteo is a prescription medication used to treat osteoporosis and increase bone mass, representing a specialized pharmaceutical supply need within the Defense Health Agency's medical procurement portfolio. This delivery order operates as a child contract under AmerisourceBergen Drug Corp's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply brand-name and generic medications, vaccines, and specialized medical commodities to support military healthcare programs worldwide. AmerisourceBergen's selection for this delivery order reflects its established capability to meet federal pharmaceutical procurement requirements through competitive award processes, positioning the company as a critical vendor for Defense Department medical supply chain operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.3k | 6/10/25 |